2,313
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Social Determinants of Adherence to Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

ORCID Icon, , , , , , & show all
Pages 610-617 | Received 06 Jul 2017, Accepted 09 Sep 2017, Published online: 11 Oct 2017

References

  • Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12:CD005305.
  • Garvey C, Bayles MP, Hamm LF, et al. Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: an official statement from the American association of cardiovascular and pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2016;36(2):75–83.
  • Hayton C, Clark A, Olive S, et al. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med. 2013;107(3):401–407.
  • Boutou AK, Tanner RJ, Lord VM et al. An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD. BMJ Open Respir Res. 2014;1(1):e000051.
  • Hogg L, Garrod R, Thornton H, McDonnell L, Bellas H, White P. Effectiveness, attendance, and completion of an integrated, system-wide pulmonary rehabilitation service for COPD: prospective observational study. COPD. 2012;9(5):546–554.
  • Heerema-Poelman A, Stuive I, Wempe JB. Adherence to a maintenance exercise program 1 year after pulmonary rehabilitation: what are the predictors of dropout? J Cardiopulm Rehabil Prev. 2013;33(6):419–426.
  • Blackstock FC, ZuWallack R, Nici L, Lareau SC. Why don't our patients with chronic obstructive pulmonary disease listen to us? The enigma of nonadherence. Ann Am Thorac Soc. 2016;13(3):317–323.
  • Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis. 2011;8(2):89–99.
  • Spruit MA, Franssen FM. What to do before pulmonary rehabilitation to improve adherence? Chron Respir Dis. 2010;7(3):131–133.
  • Fischer MJ, Scharloo M, Abbink JJ, et al. Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med. 2009;103(10):1564–1571.
  • Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic status in health research: one size does not fit all. JAMA. 2005;294(22):2879–2888.
  • Adler NE, Rehkopf DH. U.S. disparities in health: descriptions, causes, and mechanisms. Annu Rev Public Health. 2008;29:235–252.
  • Lynch JW, Kaplan GA, Salonen JT. Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic lifecourse. Soc Sci Med. 1997;44(6):809–819.
  • Lantz PM, House JS, Mero RP, Williams DR. Stress, life events, and socioeconomic disparities in health: results from the Americans' Changing Lives Study. J Health Soc Behav. 2005;46(3):274–288.
  • Lutfey K, Freese J. Toward some fundamentals of fundamental causality: socioeconomic status and health in the routine clinic visit for diabetes. American Journal of Sociology. 2005;110(5):1326–172.
  • Pampel FC, Krueger PM, Denney JT. Socioeconomic disparities in health behaviors. Annu Rev Sociol. 2010(36):349–370.
  • Cockerham WC. Health lifestyle theory and the convergence of agency and structure. J Health Soc Behav. 2005;46(1):51–67.
  • Cockerham WC. Social Causes of Health and Disease. 2nd ed. Cambridge, UK: Polity 2013. vii, 255.
  • Brown AT, Hitchcock J, Schumann C, Wells JM, Dransfield MT, Bhatt SP. Determinants of successful completion of pulmonary rehabilitation in COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:391–397.
  • Nici L, Donner C, Wouters E, et al. American thoracic society/European respiratory society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390–1413.
  • Modi AC, Cassedy AE, Quittner AL, et al. Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. J Pediatr Psychol. 2010;35(9):1028–1037.
  • Oates GR, Stepanikova I, Gamble S, Gutierrez HH, Harris WT. Adherence to airway clearance therapy in pediatric cystic fibrosis: socioeconomic factors and respiratory outcomes. Pediatr Pulmonol. 2015;50(12):1244–1252.
  • Wilbur J, Chandler P, Miller AM. Measuring adherence to a women's walking program. West J Nurs Res. 2001;23(1):8–24; discussion -32.
  • Donesky-Cuenco D, Janson S, Neuhaus J, Neilands TB, Carrieri-Kohlman V. Adherence to a home-walking prescription in patients with chronic obstructive pulmonary disease. Heart Lung. 2007;36(5):348–363.
  • Dajczman E, Wardini R, Kasymjanova G, Prefontaine D, Baltzan MA, Wolkove N. Six minute walk distance is a predictor of survival in patients with chronic obstructive pulmonary disease undergoing pulmonary rehabilitation. Can Respir J. 2015;22(4):225–229.
  • Sampson R, Morenoff J, Gannon-Rowley T. Assessing “Neighborhood Effects”: social processes and new directions in research. Annu Rev Sociol. 2002(28):443–478.
  • Diez-Roux AV, Kiefe CI, Jacobs DR Jr., et al. Area characteristics and individual-level socioeconomic position indicators in three population-based epidemiologic studies. Ann Epidemiol. 2001;11(6):395–405.
  • Barber S, Hickson DA, Kawachi I, Subramanian SV, Earls F. Neighborhood disadvantage and cumulative biological risk among a socioeconomically diverse sample of African American adults: an examination in the Jackson Heart Study. J Racial Ethn Health Disparities. 2016;3(3):444–456.
  • Blanc PD, Yen IH, Chen H, et al. Area-level socio-economic status and health status among adults with asthma and rhinitis. Eur Respir J. 2006;27(1):85–94.
  • Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001;345(2):99–106.
  • Bird CE, Seeman T, Escarce JJ, et al. Neighbourhood socioeconomic status and biological ‘wear and tear’ in a nationally representative sample of US adults. J Epidemiol Commun Health. 2010;64(10):860–865.
  • King KE, Morenoff JD, House JS. Neighborhood context and social disparities in cumulative biological risk factors. Psychosom Med. 2011;73(7):572–579.
  • Clark CR, Ommerborn MJ, Hickson DA, et al. Neighborhood disadvantage, neighborhood safety and cardiometabolic risk factors in African Americans: biosocial associations in the Jackson Heart study. PLoS One. 2013;8(5):e63254.
  • Rogers WH. Regression standard errors in clustered samples. Stata Technical Bulletin Reprints. 3. College Station, TX: Stata Press; 1993. p. 88–94.
  • Mackey K, Parchman ML, Leykum LK, Lanham HJ, Noel PH, Zeber JE. Impact of the chronic care model on medication adherence when patients perceive cost as a barrier. Prim Care Diabetes. 2012;6(2):137–142.
  • Krauskopf K, Federman AD, Kale MS, et al. Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence. COPD. 2015;12(2):151–164.
  • Tottenborg SS, Lange P, Johnsen SP, Nielsen H, Ingebrigtsen TS, Thomsen RW. Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD. Respir Med. 2016;119:160–167.
  • Kale MS, Federman AD, Krauskopf K, et al. The association of health literacy with illness and medication beliefs among patients with chronic obstructive pulmonary disease. PLoS One. 2015;10(4):e0123937.
  • Gaalema DE, Savage PD, Rengo JL, et al. Patient characteristics predictive of cardiac rehabilitation adherence. J Cardiopulm Rehabil Prev. 2017;37(2):103–110.
  • Williams DR. Race/ethnicity and socioeconomic status: measurement and methodological issues. Int J Health Serv. 1996;26(3):483–505.
  • Pearlin L. The sociological study of stress. J Health Soc Behav. 1989;30(3):241–256.
  • Zilioli S, Imami L, Slatcher RB. Socioeconomic status, perceived control, diurnal cortisol, and physical symptoms: a moderated mediation model. Psychoneuroendocrinology. 2017;75:36–43.
  • Charlson ME, Wells MT, Peterson JC, et al. Mediators and moderators of behavior change in patients with chronic cardiopulmonary disease: the impact of positive affect and self-affirmation. Transl Behav Med. 2014;4(1):7–17.
  • Sgalla G, Cerri S, Ferrari R, et al. Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy. BMJ Open Respir Res. 2015;2(1):e000065.
  • Patel MR, Kruger DJ, Cupal S, Zimmerman MA. Effect of financial stress and positive financial behaviors on cost-related nonadherence to health regimens among adults in a community-based setting. Prev Chronic Dis. 2016;13:E46.
  • Sawyer SM, Aroni RA. Sticky issue of adherence. J Paediatr Child Health. 2003;39(1):2–5.
  • Butterworth SW. Influencing patient adherence to treatment guidelines. J Manag Care Pharm. 2008;14(6 Suppl B):21–24.
  • Kreps GL, Villagran MM, Zhao X, McHorney CA, Ledford C, Weathers M, et al. Development and validation of motivational messages to improve prescription medication adherence for patients with chronic health problems. Patient Educ Couns. 2011;83(3):375–381.
  • Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60(7):657–665.
  • Kahana S, Drotar D, Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol. 2008;33(6):590–611.
  • McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868–2879.
  • Mihalko SL, Brenes GA, Farmer DF, Katula JA, Balkrishnan R, Bowen DJ. Challenges and innovations in enhancing adherence. Control Clin Trials. 2004;25(5):447–457.
  • Russell CL, Ruppar TM, Matteson M. Improving medication adherence: moving from intention and motivation to a personal systems approach. Nurs Clin North Am. 2011;46(3):271–281, v.
  • Almadana Pacheco V, Pavon Masa M, Gomez-Bastero Fernandez AP, Muniz Rodriguez AM, Tallon Moreno R, Montemayor Rubio T. Patient profile of drop-outs from a pulmonary rehabilitation program. Arch Bronconeumol. 2017;53(5):257–262.
  • Cassidy S, Turnbull S, Gardani M, Kirkwood K. Attendance at pulmonary rehabilitation classes: an exploration of demographic, physiological and psychological factors that predict completion of treatment. Chron Respir Dis. 2014;11(2):95–102.
  • Gershon AS, Dolmage TE, Stephenson A, Jackson B. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD. 2012;9(3):216–226.
  • Oates GR, Jackson BE, Partridge EE, Singh KP, Fouad MN, Bae S. Sociodemographic patterns of chronic disease: how the mid-south region compares to the rest of the country. Am J Prev Med. 2017;52(1S1):S31–S39.
  • Fan VS, Giardino ND, Blough DK, Kaplan RM, Ramsey SD, Nett Research G. Costs of pulmonary rehabilitation and predictors of adherence in the national emphysema treatment trial. COPD. 2008;5(2):105–116.
  • Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract. 2007;24(3):217–223.
  • Panagioti M, Scott C, Blakemore A, Coventry PA. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:1289–1306.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.